Medical/Pharmaceuticals
Antengene Announces First Patient Dosed in the Nivolumab Combination Portion of the Clinical Study Evaluating the ERK1/2 Inhibitor ATG-017 in Patients with Advanced Solid Tumors in the United States
- ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop, commercialize, and manufacture ATG-017 - The combination portion of the ERASER study, the first-in-human (FIH) study of ATG-017, was designed to evaluate the safety/tole...
2023-07-18 08:30
2031
Hospital Pacifica Salud Partners with Global Healthcare Resources to Boost Medical Travel Business in Panama
WEST PALM BEACH, Fla., July 18, 2023 /PRNewswire/ -- Pacifica Salud Hospital
has joined the Global Provider Network (GPN), ushering in a new era of
streamlined and easy access for American consumers and self-funded employers to
access one ofLatin America's top healthcare providers.
2023-07-18 05:19
1852
ALZHEIMER'S ASSOCIATION STATEMENT ON DONANEMAB PHASE 3 DATA REPORTED AT AAIC 2023
AMSTERDAM, July 17, 2023 /PRNewswire/ -- The data reported today by Eli Lilly from theTRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer's disease demonstrate an important advancement in Alzheimer's research and treatment. The full Phase 3 data was reported at the Alzh...
2023-07-17 21:15
1876
TradeWinds Brings Taiwanese Medical Device Manufacturers to Medicall Exhibition in Chennai
TAIPEI, July 17, 2023 /PRNewswire/ -- TradeWinds is a leading media &
exhibition agency in the health field. We are pleased to announce that these
two Taiwanese medical device manufacturers will participate inMedicall at
Chennai Trade Center from 28-30 July
2023-07-17 12:30
2289
Antengene Announces XPOVIO® Regulatory Approval in Hong Kong for the Treatment of Relapsed and/or Refractory Multiple Myeloma
* XPOVIO® (selinexor) is the first and only XPO1 inhibitor approved in Hong Kong * XPOVIO® has received regulatory approvals in 41 countries and regions includingthe United States, Israel, the United Kingdom, the European Union (the 27 member countries includingFrance and Italy), Canada, Norw...
2023-07-17 08:30
2398
MGI Empowers Life Sciences Industry with Revolutionary What If Campaign at XXIIIrd International Congress of Genetics
MELBOURNE, Australia, July 17, 2023 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today announced the launch of a global brand campaign titled "What If?" at the XXIII International Congress of Genetics (ICG), a five-yearly...
2023-07-17 07:00
2052
Red Marrow Peptide-A Major Breakthrough in Human Health Engineering
BEIJING, July 14, 2023 /PRNewswire/ -- 1.8 g! This figure refers to the weight of red marrow which can be extracted from a 100 kg young yak growing in no-human zone ofQinghai and enjoys the reputation of "the key of cardiovascular health". It is called the most perfect "blood scavenger", ...
2023-07-14 12:51
1815
Menarini Silicon Biosystems announces the launch of its new CELLSEARCH® CTC test with the DLL3 biomarker for small cell lung cancer
This new CELLSEARCH Circulating Tumor Cell (CTC) test is now available as a Research Use Only (RUO) lab service inNorth America and Europe. It is currently intended for basic and pharmaceutical research and it is the latest example of how Menarini Silicon Biosystems continues its development of c...
2023-07-13 20:00
2669
Gustave Roussy and THERYQ: France welcomes the first FLASH radiotherapy machine to treat patients
PEYNIER, France, July 13, 2023 /PRNewswire/ -- Gustave Roussy and THERYQ announce a strategic and structuring partnership to roll out and assess FLASH technology for radiotherapy. French medical technology company THERYQ, specializing in particle accelerators and radiotherapy systems, has provide...
2023-07-13 15:30
2301
Dr Catarina Ang to Join Genea Fertility's new Melbourne City clinic
MELBOURNE, Australia, July 13, 2023 /PRNewswire/ -- Genea Fertility is pleased to announce Melbourne Fertility Specialist DrCatarina Ang is joining the world-leading fertility provider. Dr Ang, an experienced gynaecologist and obstetrician, will consult from Genea Fertility's newMelbourne City cl...
2023-07-13 10:32
2229
Race executes agreement with Ardena for GMP manufacturing of RC220
* Race Oncology executes agreement with leading global contract development and manufacturing organisation, Ardena as additional partner for GMP manufacturing of flagship RC220 bistanrene formulation * Ardena has a long track record of providing sterile injectable products for all stages of c...
2023-07-13 07:30
2398
NeuroXess Documents Its Multiple Achievements in Brain-Computer Interface Research at The 2023 World Artificial Intelligence Conference
SHANGHAI, July 12, 2023 /PRNewswire/ -- On the afternoon of July 6, a forum dedicated to advances in brain-computer intelligence was held at the Shanghai World Expo Exhibition & Convention Center as a part of the 2023 World Artificial Intelligence Conference. The forum was held under the aegis of...
2023-07-12 21:41
2542
Sirnaomics to Present Latest Developments on Two Proprietary Delivery Platforms at Upcoming Industry Conferences
HONG KONG, Germantown, Md. and SUZHOU, China, July 12, 2023 /PRNewswire/ -- Sirnaomics Ltd.(the "Company", stock code: 2257, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, hereby...
2023-07-12 20:45
2367
Raya Therapeutic announces early-stage R&D collaboration with argenx
MONTREAL, July 12, 2023 /PRNewswire/ -- Raya Therapeutic Inc., ("Raya") a mission-driven company focused on the treatment of neurodegenerative diseases, has entered into an early-stage R&D collaboration with argenx. The collaboration focuses on testing combinations of Raya's pipeline of targeted ...
2023-07-12 19:07
2094
Best Presentation Award at EASL Congress 2023: First-in-class Bispecific Antibodies Anti-HBs×CD3 and Anti-HBs×CD28 Showed Strong Preclinical Efficacy in HBV Cure
SINGAPORE, July 12, 2023 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, together with researchers from the University Medical Center Hamburg-Eppendorf and Technical Unive...
2023-07-12 18:13
2398
Biosyngen's First-in-class Cell Therapy BRG01 Receives FDA Fast Track Designation
SINGAPORE, July 12, 2023 /PRNewswire/ -- On July 6, 2023, Biosyngen received an official notification from the U.S. Food and Drug Administration (FDA) granting Fast Track Designation (FTD) to its revolutionary first-in-class immunotherapy, BRG01, for the treatment of relapsed/metastatic nasophary...
2023-07-12 13:38
2691
Creating the China-Singapore Translational Medicine Center - Biosyngen's pursuit to be a leading player in the CGT industry globally hits new milestone.
SINGAPORE, July 12, 2023 /PRNewswire/ -- This is a model of cooperation between Singapore and China, more importantly, working jointly in the area of research and development. Through this initiative, China Singapore Knowledge City paths the way to attract both local and overseas therapeutic asse...
2023-07-12 10:32
2571
Sciwind Biosciences Announces Publication of Discovery, Preclinical, and Phase 1 Clinical Trial Results of Ecnoglutide (XW003) in Molecular Metabolism
HANGZHOU, China and SAN FRANCISCO, July 12, 2023 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease, today announced the publication of discovery, preclinical characteriza...
2023-07-12 10:00
2057
GI Dynamics Announces Company Rebrand as Morphic Medical® Reintroducing Flagship Product as RESET®
BOSTON, July 11, 2023 /PRNewswire/ -- GI Dynamics, creator of the world's first medical device designed to target the underlying cause of type 2 diabetes, is proud to announce its rebrand to Morphic Medical and the introduction of RESET, formally known as EndoBarrier®. This transformative shift r...
2023-07-12 07:12
2004
Putting Patients First: The Quest to Make Anticancer Cell Therapy Accessible to All
TAIPEI, July 12, 2023 /PRNewswire/ -- As cell therapies continue to rank among
the most expensive of cancer treatments,BeiGene
2023-07-12 06:00
2049
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 316 media titles]
2024-05-07 08:00
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 289 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
China-Serbia forum highlights community with shared future for mankind
[Picked up by 245 media titles]
2024-05-01 11:39
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
13580
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
9405
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
8925
